Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities With Blood Flow Restriction
Autonomical and Hemodynamic Repercussions on Excentric Resistance in Different Intensities Associated With Blood Flow Restriction: a Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
SP
-
Presidente Prudente, SP, Brazil, 19050-050
- Leonardo Kesrouani Lemos
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- male sex;
- healthy;
- aged between 18 and 35 years
Exclusion Criteria:
- smokers;
- alcoholics;
- use drugs that influenced cardiac autonomic activity;
- cardiovascular, metabolic or endocrine diseases.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: High intensity eccentric training
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
|
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
|
|
Experimental: High intensity eccentric training with blood flow restriction
high intensity (80% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure) will be performed during 6 weeks, 3 times a week.
|
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
|
|
Experimental: Low intensity eccentric training
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic will be performed during 6 weeks, 3 times a week.
|
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
|
|
Experimental: Low intensity eccentric training with blood flow restriction
A low intensity (40% isometric peak) eccentric training of the knee extensors in the isokinetic associated with a pressure cuff placed in the proximal thigh (40% of absolute occlusion pressure)will be performed during 6 weeks, 3 times a week.
|
High/low intensity eccentric training group (80% and 40% of isometric peak torque) with or not blood flow restriction.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
heart rate variability indices in the time domain
Time Frame: Change from baseline at 3rd week and 6rd week
|
mean HR, rMSSD and SDNN in ms
|
Change from baseline at 3rd week and 6rd week
|
|
heart rate variability indices analyzed in the Poincaré plot
Time Frame: Change from baseline at 3rd week and 6rd week
|
SD1 and SD2 in ms
|
Change from baseline at 3rd week and 6rd week
|
|
heart rate variability indices in the frequency domain
Time Frame: Change from baseline at 3rd week and 6rd week
|
LF and HF in nu and ms2
|
Change from baseline at 3rd week and 6rd week
|
|
vagal reentry
Time Frame: Change from 1 day at 10 day and 18 day
|
rMSSD of 30 seconds in ms
|
Change from 1 day at 10 day and 18 day
|
|
heart rate recovery
Time Frame: Change from 1 day at 10 day and 18 day
|
the recovery heart rate (HRR) in the 1st (HRR1) and 2st (HRR2) minute [bpm]
|
Change from 1 day at 10 day and 18 day
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hemodynamic parameter
Time Frame: through study completion, an average of 6 weeks
|
heart rate [bpm]
|
through study completion, an average of 6 weeks
|
|
hemodynamic parameter
Time Frame: through study completion, an average of 6 weeks
|
systolic and diastolic blood pressure [mmHg]
|
through study completion, an average of 6 weeks
|
|
hemodynamic parameter
Time Frame: through study completion, an average of 6 weeks
|
respiratory rate [irpm]
|
through study completion, an average of 6 weeks
|
|
hemodynamic parameter
Time Frame: through study completion, an average of 6 weeks
|
peripheral oxygen saturation [%]
|
through study completion, an average of 6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Franciele M Vanderlei, PhD, Paulista State University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- U1111-1232-0808
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.